HomeComparePCR vs MO

PCR vs MO: Dividend Comparison 2026

PCR yields 6.04% · MO yields 9.11%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PCR wins by $2.1K in total portfolio value
10 years
PCR
PCR
● Live price
6.04%
Share price
$19.19
Annual div
$1.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.8K
Annual income
$888.26
Full PCR calculator →
MO
Altria Group Inc.
● Live price
9.11%
Share price
$44.80
Annual div
$4.08
5Y div CAGR
4.3%
Payout ratio
78%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.7K
Annual income
$4,052.72
Full MO calculator →

Portfolio growth — PCR vs MO

📍 PCR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPCRMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PCR + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PCR pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCR
Annual income on $10K today (after 15% tax)
$513.69/yr
After 10yr DRIP, annual income (after tax)
$755.02/yr
MO
Annual income on $10K today (after 15% tax)
$774.11/yr
After 10yr DRIP, annual income (after tax)
$3,444.81/yr
At 15% tax rate, MO beats the other by $2,689.79/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCR + MO for your $10,000?

PCR: 50%MO: 50%
100% MO50/50100% PCR
Portfolio after 10yr
$28.7K
Annual income
$2,470.49/yr
Blended yield
8.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

PCR
No analyst data
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
+36.7% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCR buys
0
MO buys
11
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$MO▲ Buy$1,000 - $15,0002025-08-04
Sheri Biggs🏢 House$MO▼ Sell$1,001 - $15,0002025-03-19
Pete Sessions🏢 House$MO▼ Sell$1,001 - $15,0002024-09-10
Ro Khanna🏢 House$MO▲ Buy$1,001 - $15,0002024-03-20
Ro Khanna🏢 House$MO▲ Buy$1,001 - $15,0002024-02-13
Virginia Foxx🏢 House$MO▼ Sell$1,001 - $15,0002024-01-16
Virginia Foxx🏢 House$MO▲ Buy$1,001 - $15,0002024-01-11
Ro Khanna🏢 House$MO▼ Sell$1,001 - $15,0002024-01-10
Ro Khanna🏢 House$MO▲ Buy$1,001 - $15,0002024-01-10
Virginia Foxx🏢 House$MO▼ Sell$15,001 - $50,0002024-01-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPCRMO
Forward yield6.04%9.11%
Annual dividend / share$1.16$4.08
Payout ratio50%78%
1-year div growth0%4.1%
5-year div CAGR0%4.3%
Portfolio after 10y$29.8K$27.7K
Annual income after 10y$888.26$4,052.72
Total dividends collected$7.5K$20.9K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: PCR vs MO ($10,000, DRIP)

YearPCR PortfolioPCR Income/yrMO PortfolioMO Income/yrGap
1← crossover$11,304$604.34$10,740$949.88+$564.00PCR
2$12,734$638.47$11,601$1,086.84+$1.1KPCR
3$14,298$672.18$12,608$1,250.75+$1.7KPCR
4$16,004$705.33$13,792$1,448.20+$2.2KPCR
5$17,862$737.85$15,190$1,687.69+$2.7KPCR
6$19,882$769.65$16,851$1,980.28+$3.0KPCR
7$22,074$800.64$18,838$2,340.48+$3.2KPCR
8$24,450$830.77$21,230$2,787.44+$3.2KPCR
9$27,022$859.99$24,130$3,346.72+$2.9KPCR
10$29,802$888.26$27,676$4,052.72+$2.1KPCR

PCR vs MO: Complete Analysis 2026

PCRStock

The Simplify VettaFi Private Credit Strategy ETF (PCR) seeks income and capital appreciation by investing in a private credit strategy plus a credit hedge derivatives strategy.The private credit strategy focuses on business development companies (BDCs) and publicly-traded closed end funds (CEFs) that primarily invest in the private credit sector.Credit hedging is primarily through a proprietary long/short hedge based on total return swaps of “quality” and “junk” equities.

Full PCR Calculator →

MOConsumer Staples

Altria is a Dividend King with 54+ consecutive years of dividend increases — one of the longest streaks in American corporate history. While cigarette volumes decline, pricing power and new product categories (oral nicotine pouches via NJOY) support cash flows. The near-9% yield is among the highest in the S&P 500.

Full MO Calculator →
📬

Get this PCR vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCR vs SCHDPCR vs JEPIPCR vs OPCR vs KOPCR vs MAINPCR vs PMPCR vs BTIPCR vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.